Development Plan

2022

Preclinical Studies Completion

LignaMed expects to complete preclinical studies for LGM2605 as device in lung transplant in 2022

2023

LignaMed plans to submit device package for lung transplant in 2023

Submit IND Application to FDA

An IND submission for asthma is planned for 2023

Clinical Studies

Initiation of clinical studies for asthma is planned for 2023

Completion of clinical studies for device is planned for 2023

2024

FDA Approval & Product Launch - device for lung transplant